Radiological progression of joint damage in a longitudinal cohort of early DMARD-treated rheumatoid arthritis patients followed for 10 years

By Wick MC   Anderwald C   Weiss RJ   Imhof H   Kainberger F   Smolen JS  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 162-166

Informa Healthcare

Access to resources Recommend Favorite

Antifilaggrin Antibodies in Recent-onset Arthritis: SHORT REPORT

By Aho Kimmo   Palosuo Timo   Lukka Matti   Kurki Pekka   Isomäki Heikki   Kautiainen Hannu   von Essen Robert  

Scandinavian Journal of Rheumatology, Vol. 28, Iss. 2, 1999-05 ,pp. : 113-116

Informa Healthcare

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite

Structural progression in rheumatoid arthritis remission: can MRI predict it?

By Gandjbakhch Frederique   Foltz Violaine  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 4, 2013-08 ,pp. : 465-470

Future Medicine

Access to resources Recommend Favorite

Monoclonal antibodies in rheumatoid arthritis

By Cohen Marc   Omair Mohammed A   Keystone Edward C  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 5, 2013-10 ,pp. : 541-556

Future Medicine

Access to resources Recommend Favorite